Quantitative analysis of peptide–MHC class II interaction

By Fleckenstein B.   Wiesmüller K-H.  

Seminars in Immunology, Vol. 11, Iss. 6, 1999-12 ,pp. : 405-416

Academic Press

Access to resources Recommend Favorite

T Lymphocytes infiltrating various tumour types express the MHC class II ligand lymphocyte activation gene-3 (LAG-3): role of LAG-3/MHC class II interactions in cell-cell contacts

By Demeure C.E.   Wolfers J.   Martin-Garcia N.   Gaulard P.   Triebel F.  

European Journal of Cancer, Vol. 37, Iss. 13, 2001-09 ,pp. : 1709-1718

Elsevier

Access to resources Recommend Favorite

In situ detection of antigen-specific T cells in cryo-sections using MHC class I tetramers after dendritic cell vaccination of melanoma patients

By Vries I.   Bernsen M.   Geloof W.   Scharenborg N.   Lesterhuis W.   Rombout P.   Muijen G.   Figdor C.   Punt C.   Ruiter D.   Adema G.  

Cancer Immunology, Immunotherapy, Vol. 56, Iss. 10, 2007-10 ,pp. : 1667-1676

Springer Publishing Company

Access to resources Recommend Favorite

Fc receptors for IgG and antigen presentation on MHC class I and class II molecules

By Amigorena S.   Bonnerot C.  

Seminars in Immunology, Vol. 11, Iss. 6, 1999-12 ,pp. : 385-390

Academic Press

Access to resources Recommend Favorite

The selection of tumor variants with altered expression of classical and nonclassical MHC class I molecules: implications for tumor immune escape

By Algarra Ignacio   García-Lora Angel   Cabrera Teresa   Ruiz-Cabello Francisco   Garrido Federico  

Cancer Immunology, Immunotherapy, Vol. 53, Iss. 10, 2004-10 ,pp. : 904-910

Springer Publishing Company

Access to resources Recommend Favorite